Application 203547
- Type
- ANDA
- Sponsor
- ZYDUS PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DIFLUNISAL | DIFLUNISAL | TABLET;ORAL | 500MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 68382-530 | Diflunisal | Diflunisal | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-530 | Diflunisal | Diflunisal | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 68382-530 | Diflunisal | Diflunisal | Zydus Pharmaceuticals (USA) Inc. | ANDA | Current |
| 70771-1083 | Diflunisal | Diflunisal | Zydus Lifesciences Limited | ANDA | Current |
| 70771-1083 | Diflunisal | Diflunisal | Cadila Healthcare Limited | ANDA | Current |
| 70771-1083 | Diflunisal | Diflunisal | Cadila Healthcare Limited | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 48791 | ORIG | 2017-06-22 |